Med Spa Vacations (MDVP) 10-Q 21 Apr 21 2021 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2021	Apr. 21, 2021
Cover [Abstract]
Entity Registrant Name	MED SPA VACATIONS INC.
Entity Central Index Key	0001671077
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	true
Entity Current Reporting Status	No
Document Period End Date	Mar. 31, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		10,005,000
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	333-210922
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	47-5268172
Entity Address Address Line 1	610 Jones Ferry Road
Entity Address Address Line 2	Suite 207
Entity Address City Or Town	Carrboro
Entity Address State Or Province	NC
Entity Address Postal Zip Code	27510
City Area Code	919
Local Phone Number	933-2720
Entity Interactive Data Current	Yes

Balance Sheets

Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current Assets:
Cash	$ 115,178	$ 0
Total Current Assets	115,178	0
Total Assets	115,178	0
Current Liabilities:
Accounts payable and accrued liabilities	5,922	36,664
Due to related party	0	44,322
Note payable	150,000	0
Total Current Liabilities	155,922	80,986
Total Liabilities	155,922	80,986
Stockholders' Deficit:
Preferred stock, $0.001 par value, 25,000,000 shares authorized, no shares issued and outstanding	0	0
Common stock, $0.001 par value, 100,000,000 shares authorized, 10,005,000 shares and 14,350,000 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively	10,005	14,350
Additional paid-in capital	395,296	272,445
Accumulated deficit	(446,045)	(367,781)
Total Stockholders' Deficit	(40,744)	(80,986)
Total Liabilities and Stockholders' Deficit	$ 115,178	$ 0

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Stockholders' Deficit:
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	25,000,000	25,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value		$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	10,005,000	14,350,000
Common stock, shares outstanding	10,005,000	14,350,000

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating Expenses
General and administrative	$ 1,570	$ 0
Professional fees	75,535	0
Total Operating Expenses	77,105	0
Loss from operations	(77,105)	0
Other Income (Expense)
Interest expense	(1,159)	0
Net Other Expense	(1,159)	0
Loss Before Provision for Income Taxes	(77,105)	0
Provision for Income Taxes	0	0
Net Loss	$ (78,264)	$ 0
Net loss per common share: Basic and Diluted	$ (0.01)	$ 0
Weighted average number of common shares outstanding: Basic and Diluted	11,743,000	14,350,000

Statements of Stockholders Defi

Statements of Stockholders Deficit (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balance, shares at Dec. 31, 2019		14,350,000
Balance, amount at Dec. 31, 2019	$ (34,328)	$ 14,350	$ 272,445	$ (321,123)
Net loss	0	$ 0	0	0
Balance, shares at Mar. 31, 2020		14,350,000
Balance, amount at Mar. 31, 2020	(34,328)	$ 14,350	272,445	(321,123)
Balance, shares at Dec. 31, 2020		14,350,000
Balance, amount at Dec. 31, 2020	(80,986)	$ 14,350	272,445	(367,781)
Net loss	(78,264)	$ 0	0	(78,264)
Cancellation of common stock, shares		(4,345,000)
Cancellation of common stock, amount	0	$ (4,345)	4,345	0
Debt forgiveness by related party	118,506	$ 0	118,506	0
Balance, shares at Mar. 31, 2021		10,005,000
Balance, amount at Mar. 31, 2021	$ (40,744)	$ 10,005	$ 395,296	$ (446,045)

Statements of Cash Flow (Unaudi

Statements of Cash Flow (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash Flows from Operating Activities
Net loss	$ (78,264)	$ 0
Changes in operating assets and liabilities:
Expenses paid by related party	74,184	875
Accounts payable and accrued liabilities	(31,901)	(875)
Accrued note payable interest	1,159
Net cash used in operating activities	(34,822)	0
Cash Flows from Financing Activities
Proceed of promissory note payable	150,000
Net cash provided by Financing Activities	150,000	0
Net change in cash for period	115,178	0
Cash at beginning of period	0	8,842
Cash at end of period	115,178	8,842
Supplemental Cash Flow Information
Cash paid for income taxes	0	0
Cash paid for interest	0	$ 0
Non Cash Investing and Financing Activities
Related party debt forgiven recorded as additional paid in capital	118,506
Cancellation common stock	$ 4,345

Organization, Description of Bu

Organization, Description of Business	3 Months Ended
	Mar. 31, 2021
Organization, Description of Business
NOTE 1 - ORGANIZATION, DESCRIPTION OF BUSINESS AND GOING CONCERN	Note 1 - Organization, Description of Business Med Spa Vacations, Inc, (the “Company”), was incorporated in the State of Nevada on October 5, 2015. The Company’s office address is 610 Jones Ferry Road, Suite 207 Carrboro, NC. The Company’s original plan was to develop a business that specialized in marketing health and wellness vacations to both individuals and corporate groups looking to revitalize and develop a fuller day-to-day life. The Company was not successful in its efforts and discontinued that line of business. Since that time, the Company has been a shell company, as that term is defined in Rule 12b-2 of the Exchange Act of 1934, as amended (the “Exchange Act”) Going forward, the Company intends to seek, investigate and, if such investigation warrants, engage in a business combination with a private entity whose business presents an opportunity for the Company’s shareholders. No specific assets or businesses have been definitively identified and there is no certainty that any such assets or business will be identified or that any transactions will be consummated. On February 4, 2021, Kynson Health Limited, a BVI entity (Kynson”), which was our majority stockholder, closed stock purchase and sale transactions pursuant to which Kynson sold an aggregate of 9,985,329 restricted shares of the Company’s Common Stock to eleven purchasers at a purchase price of $0.030044 per share, or an aggregate purchase price of $299,998.60 (the “Kynson Share Sale Transaction”). Upon the closing of the Kynson Share Sale Transaction, OuYang XingYing, who controlled Kynson, and was our President, Secretary and Treasurer and sole member of the Company’s board of the directors, resigned from all positions she held with the Company and, in connection with her resignation, she relinquished her roles as the Company’s “Principal Executive Officer” and “Principal Financial and Accounting Officer.” Effective immediately upon Ms. Yang’s resignation, John D. Rollo was appointed as the Company’s President, Secretary and Treasurer, and as the sole member of the Company’s board of the directors. In connection with his appointments, Mr. Rollo was designated as the “Principal Executive Officer” and “Principal Financial and Accounting Officer” of the Company for SEC reporting purposes. In connection with and as a condition to, the consummation of the Kynson Share Sale Transaction, eleven shareholders of the Company returned an aggregate of 4,345,000 shares of the Company’s Common Stock to the Company for cancellation, in consideration for $0.001 per share. As a result of the Kynson Share Sale Transaction and simultaneous cancellation of 4,345,000 shares by eleven stockholders, there was a change in control of the Company.

Summary of significant accounti

Summary of significant accounting policies	3 Months Ended
	Mar. 31, 2021
Summary of significant accounting policies
NOTE 2 -SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Note 2 - Summary of Significant Accounting Policies Basis of Presentation of Unaudited Interim Financial Statements The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2021 and the results of operations and cash flows for the periods presented. The results of operations for the period ended March 31, 2021 are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited interim financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 30, 2021. Use of Estimates and Assumptions The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. The Company had $115,178and $0 in cash as of March 31, 2021 and December 31, 2020, respectively.

Going Concern

Going Concern	3 Months Ended
	Mar. 31, 2021
Going Concern
NOTE 3 - Going concern	Note 2 – Going Concern Going concern and Liquidity Considerations The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of March 31, 2021, the Company has reoccurring losses from operations, an accumulated deficit of $446,045 and has earned no revenues. The Company intends to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending December 31, 2021. The ability of the Company to emerge from the early stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of its business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note Payable

Note Payable	3 Months Ended
	Mar. 31, 2021
Note Payable
NOTE 4 - Note Payable	Note 3 – Note Payable On February 12, 2021, the Company received a loan in the amount of $150,000 (the “Loan”) from Hometown International Inc., a Nevada corporation (“Hometown”). To evidence the Loan, the Company issued a promissory note in the principal amount of $150,000 (the “Note”) to Hometown, with a maturity date of February 11, 2022. Interest accrues on the principal amount of the Note at the rate of six percent (6%) per annum, and shall be paid on a quarterly basis, in the amount of $2,250 per quarter, on the following dates: May 12, 2021, August 12, 2021, November 12, 2021 and February 11, 2022. The Company may prepay any amounts due under the Note without penalty or premium. During the three months ended March 31, 2021, the Company recorded interest expense of $1,159. As of March 31, 2021, the Company recorded promissory note of $150,000 and accrued interest of $1,159.

Related party transactions

Related party transactions	3 Months Ended
	Mar. 31, 2021
Related party transactions
NOTE 5 - RELATED-PARTY TRANSACTIONS	Note 4 – Related Party Transactions During the three months ended March 31, 2021 and 2020, the Company’s controlling shareholder advanced tbe Company an amount of $78,184and $875, respectively, to pay certain expenses on behalf of the Company. On February 4, 2021, the former majority shareholder of the Company, which was controlled by the Company’s former sole officer and director, canceled and released the Company from $118,506it was owed. During the three months ended March 31, 2021, the Company paid $1,000management fee to the Company’s sole Director and Officer.

Stockholders's equity

Stockholders's equity	3 Months Ended
	Mar. 31, 2021
Stockholders's equity
NOTE 6 - STOCKHOLDERS' EQUITY	Note 5 - Stockholders' Equity On February 4, 2021, eleven shareholders of the Company returned an aggregate of 4,345,000 shares (the “Cancelled Shares”) of the Company’s Common Stock to the Company for cancellation, in consideration for $4,345 ($0.001per share). The Cancelled Shares were returned to the Company’s number of authorized and unissued shares of Common Stock. As of March 31, 2021, and December 31, 2020, the Company had10,005,000and 14,350,000shares of Common Stock issued and outstanding, respectively.

Commitments

Commitments	3 Months Ended
	Mar. 31, 2021
Commitments
NOTE 7 - Commitments	Note 6 – Commitments On February 5, 2021, the Company entered into a one-year consulting agreement (the “Tryon Consulting Agreement”) with Tryon Capital LLC, a North Carolina limited liability company (“Tryon”), pursuant to which Tryon will provide the Company with financial and strategic consulting services in consideration for a consulting fee of $2,500per month. The Tryon Consulting Agreement can be terminated by either party at any time, upon 30 days’ written notice. On February 12, 2021, the Company entered into a one-year consulting agreement (the “Benzions Consulting Agreement”) with Benzions LLC, a Delaware limited liability company (“Benzions”), effective as of March 1, 2021, pursuant to which Benzions will provide certain strategic advisory and investor relations services to the Company in consideration for a consulting fee of $4,000per month. The Benzions Consulting Agreement can be terminated by either party, at any time, upon 30 days’ written notice.

Subsequent events

Subsequent events	3 Months Ended
	Mar. 31, 2021
Subsequent events
NOTE 8 - SUBSEQUENT EVENTS	Note 7 - Subsequent Events

Summary of significant accoun_2

Summary of significant accounting policies (Policies)	3 Months Ended
	Mar. 31, 2021
Summary of significant accounting policies
Basis of Presentation	The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2021 and the results of operations and cash flows for the periods presented. The results of operations for the period ended March 31, 2021 are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited interim financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 30, 2021.
Use of Estimates and Assumptions	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. The Company had $115,178and $0 in cash as of March 31, 2021 and December 31, 2020, respectively.

Organization, Description of _2

Organization, Description of business (Details Narrative) - Feburary 4, 2021 [Member] - Kynson Health Limited [Member]	3 Months Ended
	Mar. 31, 2021$ / sharesshares
Restricted shares descriptions	Kynson sold an aggregate of 9,985,329 restricted shares of the Company’s Common Stock to eleven purchasers at a purchase price of $0.030044 per share, or an aggregate purchase price of $299,998.60 (the “Kynson Share Sale Transaction”).
Purchase price of common stock	$ 0.030044
Common stock, cancellation shares | shares	4,345,000
Cancellation price per share	$ 0.001

Summary of significant accoun_3

Summary of significant accounting policies (Details Narrative) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Summary of significant accounting policies
Cash	$ 115,178	$ 0

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Summary of significant accounting policies
Accumulated Deficit	$ (446,045)	$ (367,781)

Note Payable (Details Narrative

Note Payable (Details Narrative) - USD ($)	Feb. 12, 2021	Mar. 31, 2021	Mar. 31, 2020
Summary of significant accounting policies
Loans recieved	$ 150,000
Notes payable, principal amount	$ 150,000
Promissory note, description	the Note at the rate of six percent (6%) per annum, and shall be paid on a quarterly basis, in the amount of $2,250 per quarter, on the following dates: May 12, 2021, August 12, 2021, November 12, 2021 and February 11, 2022.
Maturity date	Feb. 11, 2022
Interest expense		$ (1,159)	$ 0
Promissory note		150,000
Accrued note payable interest		$ 1,159

Related party transactions (Det

Related party transactions (Details Narrative) - Sole Director And Officer [Member] - USD ($)	Feb. 04, 2021	Mar. 31, 2021	Dec. 31, 2020
Due to related party		$ 78,184	$ 875
Cancellation owed amount	$ 118,506
Management fees		$ 1,000

Stockholders Equity (Details Na

Stockholders Equity (Details Narrative) - USD ($)	Feb. 04, 2021	Mar. 31, 2021	Dec. 31, 2020
Stockholders's equity
Cancellation of shares	4,345,000
Cancellation of shares, amount	$ 4,345
Preferred stock, par value (in dollars per share)		$ 0.001	$ 0.001
Common stock, shares issued		10,005,000	14,350,000
Common stock, shares outstanding		10,005,000	14,350,000

Commitments (Details Narrative)

Commitments (Details Narrative) - USD ($)	Feb. 12, 2021	Feb. 05, 2021
Consulting fees		$ 2,500
Benzions Consulting Agreement [Member]
Consulting fees	$ 4,000